KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $12,036,000 | +63.8% | 782,554 | +81.5% | 0.01% | -17.6% |
Q1 2014 | $7,348,000 | -32.6% | 431,201 | -48.8% | 0.02% | -29.2% |
Q4 2013 | $10,910,000 | +20.9% | 842,468 | -5.7% | 0.02% | +14.3% |
Q3 2013 | $9,027,000 | +88.5% | 893,770 | +39.4% | 0.02% | +90.9% |
Q2 2013 | $4,790,000 | – | 641,233 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |